Related Experiment Video
Updated: Aug 7, 2026

Multi-Locus Sequencing for Strain Typing of Toxoplasma gondii
Published on: May 26, 2026
LMP1 strain variants: biological and molecular properties
Bernardo A Mainou1, Nancy Raab-Traub
1Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) variants show similar transforming abilities and signaling pathway activation. Specific amino acid changes in EBV LMP1 variants do not alter their in vitro oncogenic potential.
Area of Science:
- Oncology
- Virology
- Molecular Biology
Background:
- Epstein-Barr virus (EBV) is associated with various cancers, with latent membrane protein 1 (LMP1) identified as a key oncogene.
- LMP1 drives B lymphocyte transformation and activates critical signaling pathways like PI3K-Akt and NF-kappaB.
- Six distinct LMP1 sequence variants (Alaskan, China 1, China 2, Med+, Med-, NC) exist, with varying geographical prevalence and potential roles in EBV-associated malignancies.
Purpose of the Study:
- To comprehensively characterize the biological and signaling properties of different EBV LMP1 sequence variants.
- To investigate how sequence variations in LMP1 affect its oncogenic potential and interaction with cellular signaling pathways.
- To determine if specific LMP1 variants possess enhanced or diminished transforming capabilities or signaling activities.
Main Methods:
- In vitro transformation assays using Rat-1 fibroblasts to assess oncogenic potential.
- Functional assays in HFK and BJAB cells to evaluate cell motility and homotypic adhesion.
- Analysis of PI3K-Akt and NF-kappaB signaling pathway activation by different LMP1 variants.
- Assessment of LMP1 variant binding to the E3 ubiquitin ligase component homologue of Slimb.
Main Results:
- All tested LMP1 variants demonstrated transforming potential in Rat-1 fibroblasts.
- Increased motility in HFK cells and homotypic adhesion in BJAB cells were observed across all LMP1 variants.
- While all variants activated the PI3K-Akt pathway similarly, Alaskan, China 1, and Med+ variants showed limited Slimb binding and slightly enhanced NF-kappaB signaling.
- The study found no significant enhancement or hindrance of in vitro transforming potentials or signaling properties due to signature amino acid changes in the LMP1 variants.
Conclusions:
- The distinct LMP1 variants exhibit comparable in vitro transforming abilities and impact on cell adhesion and motility.
- Variations in LMP1 sequence do not substantially alter the activation of the PI3K-Akt pathway.
- Subtle differences in NF-kappaB signaling and Slimb binding were noted for specific variants, but overall oncogenic potential remains consistent across variants.
More Related Videos
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
Published on: August 21, 2016
16:27Biophysical Assays to Probe the Mechanical Properties of the Interphase Cell Nucleus: Substrate Strain Application and Microneedle Manipulation
Published on: September 14, 2011
Related Concept Videos
Non-LTR Retrotransposons
RNA Splicing
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Modern Molecular Taxonomy